MedTrace Logo

Gut Permeability, Sensitivity and Symptomatology

NCT02358564 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2021-09-05

No results posted yet for this study

Summary

To better understand the relationship between gut barrier function and the symptomatology and pathophysiology of irritable bowel syndrome (IBS).

Conditions

  • Irritable Bowel Syndrome
  • Visceral Hypersensitivity

Interventions

PROCEDURE

Gastrointestinal Permeability Test

This test will involve ingesting a solution followed by urinalysis

PROCEDURE

Upper Endoscopy

PROCEDURE

Rectal Barostat and Infusion of Fats

Feeding tube will be placed, as well as a small balloon in the rectum.

Sponsors & Collaborators

  • University of Erlangen-Nürnberg

    collaborator OTHER

  • Heidelberg University

    collaborator OTHER

  • University of Leeds

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Madhusudan Grover, MD · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2021-03-11
Completion
2021-03-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02358564 on ClinicalTrials.gov